MEDIOS AG (ILM1.DE) Stock Fundamental Analysis
Europe - FRA:ILM1 - DE000A1MMCC8 - Common Stock
12.78 EUR
-0.62 (-4.63%)
Taking everything into account, ILM1 scores 5 out of 10 in our fundamental rating. ILM1 was compared to 32 industry peers in the Health Care Providers & Services industry. While ILM1 has a great health rating, there are worries on its profitability. ILM1 is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
ILM1 had positive earnings in the past year.
In the past year ILM1 had a positive cash flow from operations.
Each year in the past 5 years ILM1 has been profitable.
ILM1 had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
ILM1 has a Return On Assets of 2.05%. This is comparable to the rest of the industry: ILM1 outperforms 40.63% of its industry peers.
The Return On Equity of ILM1 (3.60%) is worse than 65.63% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.49%, ILM1 is doing worse than 62.50% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ILM1 is below the industry average of 7.16%.
The 3 year average ROIC (3.26%) for ILM1 is below the current ROIC(3.49%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.05% | ||
| ROE | 3.6% | ||
| ROIC | 3.49% |
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
1.3 Margins
With a Profit Margin value of 0.96%, ILM1 is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
ILM1's Profit Margin has declined in the last couple of years.
ILM1 has a worse Operating Margin (2.16%) than 71.88% of its industry peers.
ILM1's Operating Margin has declined in the last couple of years.
ILM1's Gross Margin of 9.73% is on the low side compared to the rest of the industry. ILM1 is outperformed by 65.63% of its industry peers.
In the last couple of years the Gross Margin of ILM1 has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.16% | ||
| PM (TTM) | 0.96% | ||
| GM | 9.73% |
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
2. Health
2.1 Basic Checks
ILM1 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ILM1 has more shares outstanding than it did 1 year ago.
ILM1 has more shares outstanding than it did 5 years ago.
ILM1 has a worse debt/assets ratio than last year.
2.2 Solvency
ILM1 has an Altman-Z score of 3.17. This indicates that ILM1 is financially healthy and has little risk of bankruptcy at the moment.
ILM1's Altman-Z score of 3.17 is amongst the best of the industry. ILM1 outperforms 81.25% of its industry peers.
ILM1 has a debt to FCF ratio of 3.68. This is a good value and a sign of high solvency as ILM1 would need 3.68 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 3.68, ILM1 belongs to the best of the industry, outperforming 84.38% of the companies in the same industry.
ILM1 has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.33, ILM1 belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.33 | ||
| Debt/FCF | 3.68 | ||
| Altman-Z | 3.17 |
ROIC/WACC0.53
WACC6.6%
2.3 Liquidity
ILM1 has a Current Ratio of 1.92. This is a normal value and indicates that ILM1 is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Current ratio value of 1.92, ILM1 belongs to the best of the industry, outperforming 90.63% of the companies in the same industry.
ILM1 has a Quick Ratio of 1.42. This is a normal value and indicates that ILM1 is financially healthy and should not expect problems in meeting its short term obligations.
ILM1 has a better Quick ratio (1.42) than 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.92 | ||
| Quick Ratio | 1.42 |
3. Growth
3.1 Past
ILM1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.59%, which is quite good.
Measured over the past years, ILM1 shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.00% on average per year.
The Revenue has been growing slightly by 7.02% in the past year.
ILM1 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.51% yearly.
EPS 1Y (TTM)10.59%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%150%
Revenue 1Y (TTM)7.02%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%12.41%
3.2 Future
Based on estimates for the next years, ILM1 will show a very strong growth in Earnings Per Share. The EPS will grow by 20.02% on average per year.
The Revenue is expected to grow by 4.11% on average over the next years.
EPS Next Y8.13%
EPS Next 2Y19.51%
EPS Next 3Y20.02%
EPS Next 5YN/A
Revenue Next Year7.44%
Revenue Next 2Y6.02%
Revenue Next 3Y5.5%
Revenue Next 5Y4.11%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
ILM1 is valuated rather expensively with a Price/Earnings ratio of 17.27.
ILM1's Price/Earnings is on the same level as the industry average.
ILM1's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.29.
ILM1 is valuated reasonably with a Price/Forward Earnings ratio of 8.85.
ILM1's Price/Forward Earnings ratio is rather cheap when compared to the industry. ILM1 is cheaper than 96.88% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.85. ILM1 is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.27 | ||
| Fwd PE | 8.85 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ILM1 indicates a rather cheap valuation: ILM1 is cheaper than 81.25% of the companies listed in the same industry.
ILM1's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ILM1 is cheaper than 81.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.87 | ||
| EV/EBITDA | 5.69 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ILM1 does not grow enough to justify the current Price/Earnings ratio.
ILM1's earnings are expected to grow with 20.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.13
PEG (5Y)N/A
EPS Next 2Y19.51%
EPS Next 3Y20.02%
5. Dividend
5.1 Amount
ILM1 does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:ILM1 (10/17/2025, 5:29:56 PM)
12.78
-0.62 (-4.63%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners34.48%
Inst Owner ChangeN/A
Ins Owners19.96%
Ins Owner ChangeN/A
Market Cap326.02M
Analysts85.45
Price Target25.11 (96.48%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.52%
PT rev (3m)-10.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-7.27%
EPS NY rev (3m)-0.74%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.83%
Revenue NY rev (3m)-0.15%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.27 | ||
| Fwd PE | 8.85 | ||
| P/S | 0.17 | ||
| P/FCF | 5.87 | ||
| P/OCF | 5.18 | ||
| P/B | 0.62 | ||
| P/tB | 12.32 | ||
| EV/EBITDA | 5.69 |
EPS(TTM)0.74
EY5.79%
EPS(NY)1.44
Fwd EY11.3%
FCF(TTM)2.18
FCFY17.05%
OCF(TTM)2.47
OCFY19.32%
SpS77.13
BVpS20.51
TBVpS1.04
PEG (NY)2.13
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.05% | ||
| ROE | 3.6% | ||
| ROCE | 5.75% | ||
| ROIC | 3.49% | ||
| ROICexc | 3.96% | ||
| ROICexgc | 16.81% | ||
| OM | 2.16% | ||
| PM (TTM) | 0.96% | ||
| GM | 9.73% | ||
| FCFM | 2.82% |
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
ROICexc(3y)3.82%
ROICexc(5y)3.8%
ROICexgc(3y)12.89%
ROICexgc(5y)11.48%
ROCE(3y)5.38%
ROCE(5y)5.1%
ROICexcg growth 3Y-0.85%
ROICexcg growth 5Y-8.22%
ROICexc growth 3Y-6.07%
ROICexc growth 5Y-23.77%
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
F-Score7
Asset Turnover2.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.33 | ||
| Debt/FCF | 3.68 | ||
| Debt/EBITDA | 2.15 | ||
| Cap/Depr | 19.4% | ||
| Cap/Sales | 0.38% | ||
| Interest Coverage | 2.93 | ||
| Cash Conversion | 78.16% | ||
| Profit Quality | 295.24% | ||
| Current Ratio | 1.92 | ||
| Quick Ratio | 1.42 | ||
| Altman-Z | 3.17 |
F-Score7
WACC6.6%
ROIC/WACC0.53
Cap/Depr(3y)16.31%
Cap/Depr(5y)50.4%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.49%
Profit Quality(3y)264.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.59%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%150%
EPS Next Y8.13%
EPS Next 2Y19.51%
EPS Next 3Y20.02%
EPS Next 5YN/A
Revenue 1Y (TTM)7.02%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%12.41%
Revenue Next Year7.44%
Revenue Next 2Y6.02%
Revenue Next 3Y5.5%
Revenue Next 5Y4.11%
EBIT growth 1Y48.12%
EBIT growth 3Y27.64%
EBIT growth 5Y18.54%
EBIT Next Year103.78%
EBIT Next 3Y34.34%
EBIT Next 5Y29.68%
FCF growth 1Y209.57%
FCF growth 3Y11.42%
FCF growth 5YN/A
OCF growth 1Y231.28%
OCF growth 3Y6.19%
OCF growth 5YN/A